Advertisement

Pharmacy

North Dakota leads all states for pharmacy technician pay after cost-of-living adjustments, with a mean adjusted hourly wage of $25.94, according to data published May 15 by the Bureau of Labor Statistics. Washington state tops the list on nominal pay…

Humana’s CenterWell Pharmacy has initiated full operations at its CenterWell Pharmacy mail-order distribution center in Orlando, Fla. The $83 million investment aims to increase prescription delivery capacity in the state, according to a May 27 news release. Humana has substantial Medicare Advantage,…

The FDA has approved Gilead Sciences’ Hepcludex to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis. The approval marks the first FDA-approved treatment for chronic HDV infection. Hepcludex, also known as bulevirtide-gmod injection, was…

Louisiana State University of Alexandria and the University of Louisiana at Monroe have established a new pathway program for students pursuing a career in pharmacy. The agreement allows Louisiana State University of Alexandria students enrolled in biology or chemistry bachelor’s…

CVS Health has filed a federal lawsuit challenging the constitutionality of Tennessee’s recently passed Freedom, Access and Integrity in Registered Pharmacy Act, also known as the Fair Rx Act.  The complaint, filed May 22 in the U.S. District Court for…

Advertisement

Optum Rx has named Jon Bosland as its next chief financial officer. “The PBM space is at an inflection point with rising utilization, accelerating cost pressures, and a technology landscape that is genuinely reshaping member expectations and how value gets…

Gov. Bill Lee has signed the Freedom, Access and Integrity in Registered Pharmacy Act into law, making Tennessee the second state to prohibit pharmacy benefit managers from owning or operating pharmacies.  The legislation passed despite an aggressive opposition campaign. PBMs…

Studies being presented at the American Society of Clinical Oncology’s 2026 annual meeting, being held May 29 to June 2 in Chicago, will highlight how GLP-1s could reshape oncology care, with research linking the drugs to lower cancer incidence and…

Drugmakers Biogen and Denali Therapeutics said they will discontinue development of BIIB122 for idiopathic Parkinson’s disease after the drug failed to meet primary and secondary endpoints in a phase 2b study. The phase 2b Luma study evaluated BIIB122, an investigational…

Advertisement